T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With a Reduced Intensity Regimen in Patients With Hematologic Malignancies and Aplastic Anemia

NCT03531736 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Myeloid Diseases

Interventions

DRUG: Antithymocyte globulin (Rabbit)
DRUG: fludarabine
RADIATION: total body irradiation
DRUG: cyclophosphamide
DRUG: Rituxan
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation

Sponsor

Memorial Sloan Kettering Cancer Center